The risk or severity of adverse effects can be increased when scopolamine is combined with flunarizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when scopolamine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with halcinonide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with clonidine.


The risk or severity of adverse effects can be increased when cerulenin is combined with nifedipine.


The risk or severity of adverse effects can be increased when ramipril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Olopatadine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Tianeptine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with prednisone.


The risk or severity of adverse effects can be increased when ramipril is combined with Droxicam.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Clofarabine.


The risk or severity of adverse effects can be increased when nabumetone is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when nabumetone is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with clidinium.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with hydralazine.


The risk or severity of adverse effects can be increased when captopril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with metolazone.


The risk or severity of adverse effects can be increased when quinapril is combined with diclofenac.


The risk or severity of adverse effects can be increased when alprazolam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when benazepril is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when zopiclone is combined with doxepin.


The risk or severity of adverse effects can be increased when isoflurane is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with simvastatin.


The risk or severity of adverse effects can be increased when antipyrine is combined with Apremilast.


The risk or severity of adverse effects can be increased when nicergoline is combined with propoxyphene.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with felodipine.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when brotizolam is combined with ethotoin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Pralatrexate.


The risk or severity of adverse effects can be increased when reserpine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when reserpine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with clonazepam.


The risk or severity of adverse effects can be increased when buspirone is combined with felbamate.


The risk or severity of adverse effects can be increased when reserpine is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when diflunisal is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with ouabain.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with terazosin.


The risk or severity of adverse effects can be increased when Tramadol is combined with pentazocine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when methysergide is combined with Lopinavir.


The risk or severity of adverse effects can be increased when Lofexidine is combined with tretinoin.


The risk or severity of adverse effects can be increased when Retigabine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when benazepril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with lithium ion.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Butethal.


The risk or severity of adverse effects can be increased when Bortezomib is combined with reserpine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Tramadol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when halothane is combined with selegiline.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with pramipexole.


The risk or severity of adverse effects can be increased when amphotericin b is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with isoflurane.


The risk or severity of adverse effects can be increased when nitric oxide is combined with phenytoin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with dapsone.


The risk or severity of adverse effects can be increased when zotepine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when amifostine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when prazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when cabergoline is combined with periciazine.


The risk or severity of adverse effects can be increased when itraconazole is combined with toremifene.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when trandolapril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with promethazine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Lacidipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when barnidipine is combined with nadolol.


The risk or severity of adverse effects can be increased when barnidipine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when prilocaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when paroxetine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when flunarizine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when ethopropazine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when aspirin is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when flunarizine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when procarbazine is combined with thioridazine.


The risk or severity of adverse effects can be increased when naratriptan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when cocaine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when fenoprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when diazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Vardenafil is combined with Avanafil.


The risk or severity of adverse effects can be increased when morphine is combined with codeine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when lorazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when morphine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when morphine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when pentobarbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when clomipramine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when fenoprofen is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Torasemide.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with loteprednol.


The risk or severity of adverse effects can be increased when nisoldipine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Apixaban.


The risk or severity of adverse effects can be increased when thiopental is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when prazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Clobetasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with sertraline.


The risk or severity of adverse effects can be increased when oxprenolol is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with isradipine.


The risk or severity of adverse effects can be increased when Clobetasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Efonidipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when loxapine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when atenolol is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Nepafenac is combined with alclofenac.


The risk or severity of adverse effects can be increased when topiramate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when Torasemide is combined with Valrubicin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when levorphanol is combined with mesoridazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with maprotiline.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when nabumetone is combined with paramethasone.


The risk or severity of adverse effects can be increased when nabumetone is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when suprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when aspirin is combined with Clobetasone.


The risk or severity of adverse effects can be increased when nisoldipine is combined with labetalol.


The risk or severity of adverse effects can be increased when thiopental is combined with carisoprodol.


The risk or severity of adverse effects can be increased when diazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when halothane is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with doxazosin.


The risk or severity of adverse effects can be increased when losartan is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when HEROIN is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Pramocaine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when rasagiline is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when biperiden is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when nefazodone is combined with Milnacipran.


The risk or severity of adverse effects can be increased when protriptyline is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when fenoprofen is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when amphotericin b is combined with halothane.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when quazepam is combined with enflurane.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when temazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when hydroxyamphetamine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with tiapride.


The risk or severity of adverse effects can be increased when ethopropazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when DESONIDE is combined with edrophonium.


The risk or severity of adverse effects can be increased when isoflurane is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when nimodipine is combined with nadolol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when oxycodone is combined with Articaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Agomelatine.


The risk or severity of adverse effects can be increased when prazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when amisulpride is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with nadolol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when enalapril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with scopolamine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with alclofenac.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with lovastatin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when fosinopril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Olopatadine.


The risk or severity of adverse effects can be increased when reserpine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Ivacaftor is combined with atorvastatin.


The risk or severity of adverse effects can be increased when lisinopril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when tacrolimus is combined with irinotecan.


The risk or severity of adverse effects can be increased when dyclonine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when oxycodone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when papaverine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when tolazoline is combined with papaverine.


The risk or severity of adverse effects can be increased when tolazoline is combined with nifedipine.


The risk or severity of adverse effects can be increased when enflurane is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with felodipine.


The risk or severity of adverse effects can be increased when quazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when doxepin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when quazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when quazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ILOPROST is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when sulindac is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when pramipexole is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when aspirin is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Mometasone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Talniflumate is combined with leflunomide.


The risk or severity of adverse effects can be increased when enflurane is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when cilnidipine is combined with imipramine.


The risk or severity of adverse effects can be increased when betamethasone is combined with leflunomide.


The risk or severity of adverse effects can be increased when zonisamide is combined with desipramine.


The risk or severity of adverse effects can be increased when rapamycin is combined with flunarizine.


The risk or severity of adverse effects can be increased when HEROIN is combined with carisoprodol.


The risk or severity of adverse effects can be increased when docetaxel is combined with pentostatin.


The risk or severity of adverse effects can be increased when biperiden is combined with levorphanol.


The risk or severity of adverse effects can be increased when Lapatinib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when leflunomide is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when thalidomide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Vilazodone is combined with meperidine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with methazolamide.


The risk or severity of adverse effects can be increased when Vilazodone is combined with droperidol.


The risk or severity of adverse effects can be increased when Asenapine is combined with dibucaine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with halcinonide.


The risk or severity of adverse effects can be increased when resveratrol is combined with Icatibant.


The risk or severity of adverse effects can be increased when methadone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Vilazodone is combined with imipramine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with spironolactone.


The risk or severity of adverse effects can be increased when ketorolac is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when furosemide is combined with paromomycin.


The risk or severity of adverse effects can be increased when oxycodone is combined with flurazepam.


The risk or severity of adverse effects can be increased when dyclonine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when oxycodone is combined with tizanidine.


The risk or severity of adverse effects can be increased when carprofen is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when betamethasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when procaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when isradipine is combined with nadolol.


The risk or severity of adverse effects can be increased when acetazolamide is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when thiamylal is combined with topiramate.


The risk or severity of adverse effects can be increased when methylergonovine is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when thiopental is combined with proparacaine.


The risk or severity of adverse effects can be increased when phentolamine is combined with papaverine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when lorazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when lorazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with salicylamide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when reserpine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with glutethimide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with zotepine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when reserpine is combined with oxazepam.


The risk or severity of adverse effects can be increased when tropicamide is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Alvimopan.


The risk or severity of adverse effects can be increased when docetaxel is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when docetaxel is combined with lomustine.


The risk or severity of adverse effects can be increased when docetaxel is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when bromazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when bromazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when flunisolide is combined with edrophonium.


The risk or severity of adverse effects can be increased when nefazodone is combined with loxapine.


The risk or severity of adverse effects can be increased when nefazodone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when ethanol is combined with methylphenidate.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with alclofenac.


The risk or severity of adverse effects can be increased when estazolam is combined with bromazepam.


The risk or severity of adverse effects can be increased when azelastine is combined with Mometasone.


The risk or severity of adverse effects can be increased when rapamycin is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when bumetanide is combined with carvedilol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with topiramate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when lisinopril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when sevoflurane is combined with terazosin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with clonidine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with amisulpride.


The risk or severity of adverse effects can be increased when etizolam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when rasagiline is combined with Pipamperone.


The risk or severity of adverse effects can be increased when physostigmine is combined with nicotine.


The risk or severity of adverse effects can be increased when physostigmine is combined with Cevimeline.


The risk or severity of adverse effects can be increased when tolmetin is combined with dexamethasone.


The risk or severity of adverse effects can be increased when etizolam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when procyclidine is combined with meperidine.


The risk or severity of adverse effects can be increased when imipramine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when risperidone is combined with tetracaine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when fosinopril is combined with doxazosin.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with terazosin.


The risk or severity of adverse effects can be increased when Conivaptan is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when bepridil is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when pirenzepine is combined with oxybutynin.


The risk or severity of adverse effects can be increased when dyclonine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when meperidine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with desipramine.


The risk or severity of adverse effects can be increased when flunisolide is combined with Demecarium.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with butamben.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Olmesartan is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when timolol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Melatonin is combined with trimipramine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when medrysone is combined with enoxacin.


The risk or severity of adverse effects can be increased when propofol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when cetirizine is combined with levodopa.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when pramipexole is combined with Riociguat.


The risk or severity of adverse effects can be increased when trandolapril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when flumethasone is combined with donepezil.


The risk or severity of adverse effects can be increased when Butoconazole is combined with fluvastatin.


The risk or severity of adverse effects can be increased when trandolapril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with etizolam.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with loratadine.


The risk or severity of adverse effects can be increased when etodolac is combined with equilin.


The risk or severity of adverse effects can be increased when trandolapril is combined with Droxicam.


The risk or severity of adverse effects can be increased when pentazocine is combined with prilocaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with mecamylamine.


The risk or severity of adverse effects can be increased when isoflurane is combined with trazodone.


The risk or severity of adverse effects can be increased when fenbufen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when valsartan is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Miltefosine is combined with nifedipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when levorphanol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when estrone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when procyclidine is combined with Tramadol.


The risk or severity of adverse effects can be increased when Ephedrine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when pentazocine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Tiotropium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when mesalamine is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Bretylium.


The risk or severity of adverse effects can be increased when bupivacaine is combined with halothane.


The risk or severity of adverse effects can be increased when temazepam is combined with cetirizine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Icatibant is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when proparacaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with thiamylal.


The risk or severity of adverse effects can be increased when propoxyphene is combined with promethazine.


The risk or severity of adverse effects can be increased when Posaconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with moclobemide.


The risk or severity of adverse effects can be increased when fludiazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Butethal is combined with nefazodone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when fludiazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with bepridil.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Butethal is combined with doxepin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Retigabine.


The risk or severity of adverse effects can be increased when terbinafine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when clorazepate is combined with amobarbital.


The risk or severity of adverse effects can be increased when metoprolol is combined with losartan.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with thalidomide.


The risk or severity of adverse effects can be increased when phenytoin is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when quetiapine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when pentamidine is combined with diltiazem.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Butethal.


The risk or severity of adverse effects can be increased when Tixocortol is combined with galanthamine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when acebutolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when apraclonidine is combined with terazosin.


The risk or severity of adverse effects can be increased when Torasemide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with pramipexole.


The risk or severity of adverse effects can be increased when prilocaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Torasemide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when METAXALONE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Spirapril is combined with etodolac.


The risk or severity of adverse effects can be increased when floctafenine is combined with suprofen.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when floctafenine is combined with loteprednol.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Pirlindole is combined with lithium ion.


The risk or severity of adverse effects can be increased when terconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when fenbufen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Micafungin is combined with Amrinone.


The risk or severity of adverse effects can be increased when etizolam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with thiamylal.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with desipramine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with oxymorphone.


The risk or severity of adverse effects can be increased when terbutaline is combined with nylidrin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with halothane.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Bretylium.


The risk or severity of adverse effects can be increased when midazolam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when labetalol is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when triazolam is combined with doxepin.


The risk or severity of adverse effects can be increased when labetalol is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Lurasidone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when ramipril is combined with quetiapine.


The risk or severity of adverse effects can be increased when Salsalate is combined with antipyrine.


The risk or severity of adverse effects can be increased when Tadalafil is combined with Avanafil.


The risk or severity of adverse effects can be increased when dibucaine is combined with sertraline.


The risk or severity of adverse effects can be increased when triamterene is combined with enalapril.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ifosfamide is combined with leflunomide.


The risk or severity of adverse effects can be increased when ketamine is combined with scopolamine.


The risk or severity of adverse effects can be increased when estazolam is combined with olanzapine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with efavirenz.


The risk or severity of adverse effects can be increased when propofol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when propofol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with aspirin.


The risk or severity of adverse effects can be increased when isoflurane is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with hydralazine.


The risk or severity of adverse effects can be increased when imipramine is combined with ritodrine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Metipranolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with estazolam.


The risk or severity of adverse effects can be increased when mesoridazine is combined with loratadine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Paliperidone.


The risk or severity of adverse effects can be increased when diazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with maprotiline.


The risk or severity of adverse effects can be increased when nicergoline is combined with felodipine.


The risk or severity of adverse effects can be increased when codeine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Difenoxin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when hydromorphone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when tioconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with amisulpride.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when maprotiline is combined with sertraline.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with haloperidol.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when doxepin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with furazolidone.


The risk or severity of adverse effects can be increased when etizolam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with ketoprofen.


The risk or severity of adverse effects can be increased when etizolam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nicardipine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with floctafenine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with efavirenz.


The risk or severity of adverse effects can be increased when dopamine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when bromazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when amisulpride is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when zopiclone is combined with Perospirone.


The risk or severity of adverse effects can be increased when Etomidate is combined with trazodone.


The risk or severity of adverse effects can be increased when celecoxib is combined with Salsalate.


The risk or severity of adverse effects can be increased when codeine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when sotalol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when etodolac is combined with nimesulide.


The risk or severity of adverse effects can be increased when pimozide is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when ketorolac is combined with acemetacin.


The risk or severity of adverse effects can be increased when morphine is combined with terazosin.


The risk or severity of adverse effects can be increased when risperidone is combined with diazepam.


The risk or severity of adverse effects can be increased when halothane is combined with lisinopril.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with levodopa.


The risk or severity of adverse effects can be increased when halothane is combined with trimipramine.


The risk or severity of adverse effects can be increased when halothane is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when floctafenine is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with ethotoin.


The risk or severity of adverse effects can be increased when propofol is combined with Etomidate.


The risk or severity of adverse effects can be increased when propofol is combined with bupivacaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with fludiazepam.


The risk or severity of adverse effects can be increased when estazolam is combined with Melatonin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when estazolam is combined with promethazine.


The risk or severity of adverse effects can be increased when estazolam is combined with clonazepam.


The risk or severity of adverse effects can be increased when felbamate is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when lisinopril is combined with penbutolol.


The risk or severity of adverse effects can be increased when sulpiride is combined with clomipramine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Eplerenone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with methazolamide.


The risk or severity of adverse effects can be increased when acemetacin is combined with equilin.


The risk or severity of adverse effects can be increased when tiapride is combined with butalbital.


The risk or severity of adverse effects can be increased when nalbuphine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when nalbuphine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with desipramine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with pancuronium.


The risk or severity of adverse effects can be increased when butabarbital is combined with mesoridazine.


The risk or severity of adverse effects can be increased when butabarbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when isradipine is combined with prazosin.


The risk or severity of adverse effects can be increased when amisulpride is combined with doxepin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Ramelteon.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when doxepin is combined with Bambuterol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with amcinonide.


The risk or severity of adverse effects can be increased when ipratropium is combined with tubocurarine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with zotepine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when ipratropium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when HEROIN is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when terbinafine is combined with manidipine.


The risk or severity of adverse effects can be increased when procaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when halothane is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Trospium is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when halothane is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when dibucaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when dibucaine is combined with promethazine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Perospirone.


The risk or severity of adverse effects can be increased when halothane is combined with baclofen.


The risk or severity of adverse effects can be increased when rivastigmine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with ethopropazine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when dibucaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when lorazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when rasagiline is combined with Asenapine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with citalopram.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with HEROIN.


The risk or severity of adverse effects can be increased when Isoconazole is combined with pravastatin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when olanzapine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when propranolol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Nebivolol.


The risk or severity of adverse effects can be increased when amiodarone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Torasemide.


The risk or severity of adverse effects can be increased when leflunomide is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when amobarbital is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when estazolam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Butethal.


The risk or severity of adverse effects can be increased when phenytoin is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when ketoconazole is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when ondansetron is combined with flunarizine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when selegiline is combined with Clevidipine.


The risk or severity of adverse effects can be increased when acemetacin is combined with Mometasone.


The risk or severity of adverse effects can be increased when thiamylal is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Torasemide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when thiamylal is combined with levodopa.


The risk or severity of adverse effects can be increased when methylene blue is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Bretylium is combined with Clevidipine.


The risk or severity of adverse effects can be increased when phenylephrine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with clonazepam.


The risk or severity of adverse effects can be increased when loratadine is combined with efavirenz.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with haloperidol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with enalapril.


The risk or severity of adverse effects can be increased when sulindac is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when tolnaftate is combined with manidipine.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with clomipramine.


The risk or severity of adverse effects can be increased when methylene blue is combined with bezafibrate.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when diclofenac is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when amobarbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with indapamide.


The risk or severity of adverse effects can be increased when diclofenac is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when amobarbital is combined with prilocaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with dibucaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Perospirone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with leflunomide.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when losartan is combined with salicylamide.


The risk or severity of adverse effects can be increased when zopiclone is combined with scopolamine.


The risk or severity of adverse effects can be increased when codeine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when codeine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when epinephrine is combined with nylidrin.


The risk or severity of adverse effects can be increased when indapamide is combined with Riociguat.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with suprofen.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with carbamazepine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when secobarbital is combined with topiramate.


The risk or severity of adverse effects can be increased when nadolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when risperidone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with papaverine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Tramadol is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when flumazenil is combined with olanzapine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when ketoprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when codeine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when zopiclone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when benazepril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with tiapride.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Mometasone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when clozapine is combined with Bretylium.


The risk or severity of adverse effects can be increased when mecamylamine is combined with nifedipine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when benazepril is combined with nicardipine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with papaverine.


The risk or severity of adverse effects can be increased when biperiden is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trimipramine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with fosinopril.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with labetalol.


The risk or severity of adverse effects can be increased when tretinoin is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when enflurane is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Droxicam is combined with medrysone.


The risk or severity of adverse effects can be increased when lisinopril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Isoconazole is combined with lovastatin.


The risk or severity of adverse effects can be increased when ramipril is combined with alclofenac.


The risk or severity of adverse effects can be increased when morphine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when codeine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when thioridazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when triprolidine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when codeine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when morphine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with metrizamide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when benazepril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when alprazolam is combined with perphenazine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with promethazine.


The risk or severity of adverse effects can be increased when alprazolam is combined with levorphanol.


The risk or severity of adverse effects can be increased when thioridazine is combined with prazosin.


The risk or severity of adverse effects can be increased when zopiclone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with trimipramine.


The risk or severity of adverse effects can be increased when butamben is combined with promethazine.


The risk or severity of adverse effects can be increased when butamben is combined with clonazepam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with lisinopril.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when tiagabine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when fenoprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when selegiline is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when furazolidone is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when enalapril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with enalapril.


The risk or severity of adverse effects can be increased when selegiline is combined with Bambuterol.


The risk or severity of adverse effects can be increased when enalapril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when nabumetone is combined with antipyrine.


The risk or severity of adverse effects can be increased when brimonidine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with paramethasone.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with olanzapine.


The risk or severity of adverse effects can be increased when procaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when temazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with omeprazole.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Vardenafil.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with maprotiline.


The risk or severity of adverse effects can be increased when linezolid is combined with Paliperidone.


The risk or severity of adverse effects can be increased when meprobamate is combined with Butethal.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when meprobamate is combined with amobarbital.


The risk or severity of adverse effects can be increased when midazolam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when meprobamate is combined with lithium ion.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with butalbital.


The risk or severity of adverse effects can be increased when epoprostenol is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Perospirone is combined with clonidine.


The risk or severity of adverse effects can be increased when quazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with nimodipine.


The risk or severity of adverse effects can be increased when quazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when zopiclone is combined with paroxetine.


The risk or severity of adverse effects can be increased when quazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when ketamine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when oxycodone is combined with Drospirenone.


The risk or severity of adverse effects can be increased when Isoconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when paramethasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when diflunisal is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with topiramate.


The risk or severity of adverse effects can be increased when docetaxel is combined with Trilostane.


The risk or severity of adverse effects can be increased when methadone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Bretylium.


The risk or severity of adverse effects can be increased when prednisone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with etizolam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when reserpine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when captopril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Eletriptan is combined with duloxetine.


The risk or severity of adverse effects can be increased when reserpine is combined with benzocaine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when amobarbital is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when pergolide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when calcium lactate is combined with Calcipotriol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with HEROIN.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with papaverine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with nifedipine.


The risk or severity of adverse effects can be increased when ketamine is combined with Halazepam.


The risk or severity of adverse effects can be increased when promazine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with etizolam.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with oxybutynin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when tolmetin is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with promethazine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with halcinonide.


The risk or severity of adverse effects can be increased when buprenorphine is combined with rasagiline.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with difluprednate.


The risk or severity of adverse effects can be increased when diflorasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when halcinonide is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when carprofen is combined with salicylic acid.


The risk or severity of adverse effects can be increased when halcinonide is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when diazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when Nepafenac is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when reserpine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when pargyline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when nifedipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when oxprenolol is combined with flunarizine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Epirubicin is combined with leflunomide.


The risk or severity of adverse effects can be increased when indomethacin is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when budesonide is combined with ambenonium.


The risk or severity of adverse effects can be increased when enalapril is combined with carprofen.


The risk or severity of adverse effects can be increased when reserpine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with butalbital.


The risk or severity of adverse effects can be increased when reserpine is combined with thiothixene.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with methazolamide.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when clozapine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when captopril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Arotinolol is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Apremilast is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with methazolamide.


The risk or severity of adverse effects can be increased when butenafine is combined with nicardipine.


The risk or severity of adverse effects can be increased when Apremilast is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Vecuronium is combined with butorphanol.


The risk or severity of adverse effects can be increased when butorphanol is combined with trimipramine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when tolmetin is combined with antipyrine.


The risk or severity of adverse effects can be increased when butorphanol is combined with procaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when equilin is combined with fleroxacin.


The risk or severity of adverse effects can be increased when buspirone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with medrysone.


The risk or severity of adverse effects can be increased when reserpine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when morphine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when topiramate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nitrendipine is combined with atenolol.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with tiagabine.


The risk or severity of adverse effects can be increased when clonidine is combined with indapamide.


The risk or severity of adverse effects can be increased when benzphetamine is combined with terbutaline.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Phenelzine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Treprostinil is combined with carprofen.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when Phenelzine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when cilnidipine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with doxepin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when promethazine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with nefazodone.


The risk or severity of adverse effects can be increased when betaxolol is combined with spironolactone.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with methadone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when labetalol is combined with dobutamine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with furazolidone.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with oxycodone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with dantrolene.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with nifedipine.


The risk or severity of adverse effects can be increased when nabumetone is combined with celecoxib.


The risk or severity of adverse effects can be increased when Telmisartan is combined with quinapril.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with trazodone.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with papaverine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with Echothiophate.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when linezolid is combined with mesoridazine.


The risk or severity of adverse effects can be increased when linezolid is combined with maprotiline.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with zonisamide.


The risk or severity of adverse effects can be increased when buprenorphine is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when loratadine is combined with levodopa.


The risk or severity of adverse effects can be increased when D-mannitol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Desloratadine is combined with tolterodine.


The risk or severity of adverse effects can be increased when pentazocine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when acebutolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when loratadine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when loteprednol is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when loratadine is combined with amoxapine.


The risk or severity of adverse effects can be increased when felodipine is combined with carvedilol.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with primidone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with sulfadiazine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Cevimeline.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with nicotine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when nitric oxide is combined with minoxidil.


The risk or severity of adverse effects can be increased when papaverine is combined with carvedilol.


The risk or severity of adverse effects can be increased when flunarizine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with diazepam.


The risk or severity of adverse effects can be increased when metaproterenol is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when furazolidone is combined with buspirone.


The risk or severity of adverse effects can be increased when diflunisal is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when furazolidone is combined with oxycodone.


The risk or severity of adverse effects can be increased when levorphanol is combined with Torasemide.


The risk or severity of adverse effects can be increased when lorazepam is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when carbamazepine is combined with proparacaine.


The risk or severity of adverse effects can be increased when methysergide is combined with glyburide.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Halazepam.


The risk or severity of adverse effects can be increased when methysergide is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with tiagabine.


The risk or severity of adverse effects can be increased when indomethacin is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when hydromorphone is combined with tiagabine.


The risk or severity of adverse effects can be increased when enflurane is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Spirapril is combined with diclofenac.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with zonisamide.


The risk or severity of adverse effects can be increased when pentazocine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when rasagiline is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with triamcinolone.


The risk or severity of adverse effects can be increased when prazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with loratadine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with prilocaine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with imipramine.


The risk or severity of adverse effects can be increased when nabumetone is combined with diflorasone.


The risk or severity of adverse effects can be increased when thiothixene is combined with Difenoxin.


The risk or severity of adverse effects can be increased when barnidipine is combined with Conivaptan.


The risk or severity of adverse effects can be increased when trazodone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when pentazocine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when Propacetamol is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when trazodone is combined with sumatriptan.


The risk or severity of adverse effects can be increased when ibuprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with bumetanide.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with azelastine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with quinapril.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Melatonin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when procaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Eletriptan is combined with mirtazapine.


The risk or severity of adverse effects can be increased when tizanidine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when terconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when rasagiline is combined with droperidol.


The risk or severity of adverse effects can be increased when aspirin is combined with equilin.


The risk or severity of adverse effects can be increased when ethanol is combined with rasagiline.


The risk or severity of adverse effects can be increased when levodopa is combined with Phenelzine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when thiopental is combined with Flibanserin.


The risk or severity of adverse effects can be increased when methazolamide is combined with felodipine.


The risk or severity of adverse effects can be increased when midazolam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with vinorelbine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when tizanidine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Difenoxin.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with indomethacin.


The risk or severity of adverse effects can be increased when fluocinonide is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when thiopental is combined with citalopram.


The risk or severity of adverse effects can be increased when azelastine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Apremilast.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with deslanoside.


The risk or severity of adverse effects can be increased when cilazapril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when diazepam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when minoxidil is combined with quinapril.


The risk or severity of adverse effects can be increased when pancuronium is combined with meperidine.


The risk or severity of adverse effects can be increased when minoxidil is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when procarbazine is combined with formoterol.


The risk or severity of adverse effects can be increased when cetirizine is combined with citalopram.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nadolol.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Riociguat.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when DESONIDE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when methysergide is combined with mifepristone.


The risk or severity of adverse effects can be increased when lorazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with hydralazine.


The risk or severity of adverse effects can be increased when valsartan is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Tramadol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when clozapine is combined with dantrolene.


The risk or severity of adverse effects can be increased when amifostine is combined with rasagiline.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clozapine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when prilocaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when clozapine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when triazolam is combined with clomipramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when fenoldopam is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when zonisamide is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Normethadone is combined with levodopa.


The risk or severity of adverse effects can be increased when gemfibrozil is combined with Ezetimibe.